Sea Limited Announces Share Repurchase Program
SINGAPORE–(BUSINESS WIRE)–Sea Limited (NYSE: SE) (“Sea” or the “Company”) today announced that its board of directors has authorized a share... Read more.
Pride and Nostalgia: Emotional Connection Motivates Two-Thirds of Canadians to Seek Canadian-Made Gifts
Your Canadian gifts are covered: shop Purdys Chocolatier’s Holiday collection online and at your local Purdys shop now VANCOUVER, British Columbia–(BUSINESS... Read more.
Polpharma Biologics Confirms U.S. Launch of Tyruko® (natalizumab), the First and Only Biosimilar for Multiple Sclerosis
AMSTERDAM–(BUSINESS WIRE)–Polpharma Biologics, a biopharmaceutical company group focused on biosimilars development and manufacturing, today confirmed... Read more.
Caranx Medical Announces First Clinical Use of the TAVIPILOT Soft, Cleared by FDA for Commercial in July: the World First AI Software for Real-Time Intra-Operative Guidance of Transcatheter Heart Valve Implantation
NICE, France–(BUSINESS WIRE)–Caranx Medical (“Caranx”), a French medical device company specializing in the development of an autonomous robot to... Read more.
Lone Star Acquires Multi-Asset Real Estate Portfolio from St. James’s Place
DALLAS & NEW YORK & LONDON & TOKYO–(BUSINESS WIRE)–Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real... Read more.
Bureau Veritas appoints Santiago Arias Duval as Executive Vice-President for the Americas region
PARIS–(BUSINESS WIRE)–Bureau Veritas, a global leader in Testing, Inspection and Certification (TIC), is pleased to announce the appointment of Santiago... Read more.
MassMutual and Barings Announce Investment by MS&AD Insurance Group Holdings for 18% Stake in Barings
Strategic partnership with MS&AD to accelerate Barings’ growth with additional capital and assets SPRINGFIELD, Mass. & CHARLOTTE, N.C.–(BUSINESS... Read more.
Deciphera Announces the Opening of a New Office in Zug, Switzerland
– New 733-square-meter office will allow Deciphera to strategically expand its operations and further advance its commercial reach in Europe – OSAKA, Japan &... Read more.
ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline
At ASDS 2025, Galderma unveiled pivotal new data from its range of pioneering Restylane® hyaluronic acid (HA) injectables, highlighting its versatility in improving... Read more.
Innate Pharma to Present at Jefferies Global Healthcare Conference
MARSEILLE, France–(BUSINESS WIRE)–#Congress–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”)... Read more.